Trials / Completed
CompletedNCT00373776
Miltefosine for Mucosal Leishmaniasis
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 75 (planned)
- Sponsor
- AB Foundation · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This trial will study miltefosine as a treatment for mucosal leishmaniasis.
Detailed description
Treat bolivian mucosal leishmaniasis with miltefosine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | miltefosine 2.5 mg/kg/day for 28 days |
Timeline
- Start date
- 2004-04-01
- Completion
- 2006-05-01
- First posted
- 2006-09-08
- Last updated
- 2006-09-08
Locations
1 site across 1 country: Bolivia
Source: ClinicalTrials.gov record NCT00373776. Inclusion in this directory is not an endorsement.